PGHH Share Price Target 2035

CAGR-based price projection for Procter & Gamble Hygiene and Health Care Limited (PGHH) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (-5.0% CAGR)
Rs 4,184
2035 Target
Base Case (-32.2% CAGR)
Rs 202
2035 Target
Bull Case (-48.3% CAGR)
Rs 18
2035 Target

Current Market Snapshot

CMP: Rs 6,639.00
52W High: Rs 10,429.50
52W Low: Rs 6,639.00
1Y CAGR: -54.0%
3Y CAGR: -32.2%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 6,307 Rs 4,503 Rs 3,435
2028 Rs 5,992 Rs 3,054 Rs 1,777
2029 Rs 5,692 Rs 2,072 Rs 920
2030 Rs 5,408 Rs 1,405 Rs 476
2031 Rs 5,137 Rs 953 Rs 246
2032 Rs 4,880 Rs 646 Rs 127
2033 Rs 4,636 Rs 438 Rs 66
2034 Rs 4,404 Rs 297 Rs 34
2035 Rs 4,184 Rs 202 Rs 18

Other PGHH Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the PGHH share price target for 2035?

Based on historical growth analysis, the PGHH share price target for 2035 ranges from Rs 4,184 (conservative) to Rs 202 (base case) to Rs 18 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of PGHH?

The current market price of PGHH (Procter & Gamble Hygiene and Health Care Limited) is Rs 6,639.00. The 52-week high is Rs 10,429.50 and 52-week low is Rs 6,639.00.

Is PGHH a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for PGHH price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at -5.0% CAGR), Base (-32.2% CAGR), and Bull (optimistic at -48.3% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.